SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

The FDA issued a Complete Response Letter for ivonescimab in EGFR-mutated lung cancer, saying the application lacked statistically significant overall-survival evidence despite a strong progression-free-survival result. Traders view the decision as a setback, but debate whether it is limited to that indication or undermines the broader thesis, which many say now hinges on the HARMONi-3 first-line lung cancer readout.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharmas upcoming Phase 3 APPROACH topline readout for HLP003 in adjunctive major depressive disorder is the dominant focus, with traders treating the results as a high-stakes catalyst. Bulls emphasize the treatments add-on design and potential advantages, while skeptics question whether efficacy will hold up in Phase 3 and raise concerns about dilution and execution.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,112,050. The last known price of Bitcoin is 63,437.21016941 USD and is down -7.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $45,086,253,428.50 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and volatile rebound dominate discussion, with traders debating whether heavy selling and liquidations have exhausted themselves or signal further downside. Some attribute pressure to broader risk-off conditions, ETF outflows, and Binance-related concerns, while others view oversold technical readings and support as signs of a possible bounce.

JasmyCoin (JASMY) is a cryptocurrency launched in 2016and operates on the Ethereum platform. JasmyCoin has a current supply of 50,000,000,000 with 49,444,999,677.16957912 in circulation. The last known price of JasmyCoin is 0.00312867 USD and is down -5.82 over the last 24 hours. It is currently trading on 374 active market(s) with $10,034,947.48 traded over the last 24 hours. More information can be found at https://www.jasmy.co.jp/en_company.html.

JasmyCoin

JASMYs prolonged decline toward recent lows is fueling debate, with some holders continuing to buy the dip while critics cite weak execution and the teams apparent focus on Janction (JCT) as reasons for the tokens underperformance. Some traders also point to broader crypto-market weakness, but the dominant conversation is frustration over JASMYs price action versus optimism about a possible recovery.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,752,062,860.16806072. The last known price of Dogecoin is 0.05689686 USD and is down -11.89 over the last 24 hours. It is currently trading on 1545 active market(s) with $1,128,721,930.78 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention amid a broad crypto selloff and a steep decline that traders describe as pushing it toward multiyear lows. The conversation is split between holders calling the weakness a buying opportunity and bears warning of further losses, with many questioning whether DOGE can regain momentum.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depots upcoming quarterly report is drawing attention, with traders focused on comparable sales, customer traffic, margins and any guidance changes. Some expect the recent rally to continue, while others see weak housing and renovation demand, high rates and reliance on tariff refunds as risks to the outlook.

Cardano (ADA) is a cryptocurrency launched in 2017. Cardano has a current supply of 44,994,648,344.194204 with 36,816,370,531.313927 in circulation. The last known price of Cardano is 0.14666837 USD and is down -12.66 over the last 24 hours. It is currently trading on 1753 active market(s) with $480,085,527.58 traded over the last 24 hours. More information can be found at https://www.cardano.org.

Cardano

Cardanos sharp decline and prolonged underperformance are driving debate, with bearish traders tying concerns to Charles Hoskinsons comments that the networks roadmap is complete and development is now community-led. Some interpret this as a sign the project has been abandoned, while holders argue the infrastructure is finished and are buying the dip or anticipating a rebound.

Shiba Inu (SHIB) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Shiba Inu has a current supply of 589,495,699,860,951.91490568 with 589,238,106,731,035.4551592 in circulation. The last known price of Shiba Inu is 0.00000379 USD and is down -10.85 over the last 24 hours. It is currently trading on 1128 active market(s) with $78,538,817.41 traded over the last 24 hours. More information can be found at https://shibatoken.com/.

Shiba Inu

SHIB is drawing attention amid prolonged weakness and repeated bearish technical commentary, with traders lamenting its lack of momentum and speculating about further declines. Holders remain divided, as some keep accumulating and hope for a meme-coin rebound while others question the tokens utility and prospects.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Strong interim REGAIN results in recurrent glioblastoma, presented at SNO, are driving attention, with traders focused on the encouraging early response and survival signals and managements discussion of the data. The community is largely bullish, though some caution that the cohort is small and want more evidence on durability and the path to a possible market submission.

Autonomi (ANT) is a cryptocurrency launched in 2025and operates on the Arbitrum platform. Autonomi has a current supply of 1,200,000,000 with 346,331,579 in circulation. The last known price of Autonomi is 0.03106712 USD and is down -0.55 over the last 24 hours. It is currently trading on 15 active market(s) with $122,300.99 traded over the last 24 hours. More information can be found at https://autonomi.com.

Aragon

Most of the attention appears to come from confusion between Aragons $ANT.X ticker and Anthropics planned IPO, with traders debating the IPOs valuation and potential effect on tech and crypto markets. Aragon-specific posts instead discuss its DAO governance tools and its completed token redemption initiative; no clear new catalyst for the Aragon token dominates.

statis crypto Watchlist

Ethereum

Solana

Ripple

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


mariosouccar

Mario Souccar